Abstract
Several animal models of breast cancer have been developed to study various aspects of breast cancer biology. Substantial evidence suggests that the N-methylnitrosourea (MNU) animal model mimics human breast cancer in many respects. It has therefore been used extensively to evaluate preventive and therapeutic agents for human breast cancer. Chemically induced rodent models are also suitable for studying malignant progression. Recently, Liska et al. [7] established two protocols of MNU administration depending on the animal’s age and number of applications of carcinogen, with the aim of investigating the advanced stages of mammary gland tumours. We used the same protocol as Liska but have obtained substantially different results. These results are presented and discussed in the frame of suggested key drawbacks of the MNU induced breast cancer rat model, as a contribution to the debate about the suitability of that model for evaluating preventive and therapeutic agents.
References
Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Clarke R (1996) Animal models of breast cancer: their diversity and role in biomedical research. Breast Cancer Res Treat 39:1–6
Russo J, Russo IH (1996) Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 39:7–20
McCormick DL, Adamowski CB, Fiks A et al (1981) Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea. Cancer Res 41:1690–1694
Isaacs JT (1986) Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958–3963
Thompson HJ, Adlakha H (1991) Dose-responsive induction of mammary gland carcinomas by the intraperitoneal injection of 1-methyl-1-nitrosourea. Cancer Res 51:3411–3415
Liska J, Galbavy S, Macejova D et al (2000) Histopathology of mammary tumours in female rats treated with 1-methyl-1-nitrosourea. Endocr Regul 34:91–96
Thompson HJ, Adlakha H, Singh M (1992) Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 13:1535–1539
Thompson HJ, McGinley JN, Rothhammer K et al (1995) Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis 16:2407–2411
Russo J, Russo IH (2000) Atlas and histologic classification of tumors of the rat mammary gland. Journal of Mammary Gland Biology and Neoplasia 5:187–200
Chan MM, Lu X, Merchant FM et al (2005) Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer. Carcinogenesis 26:1343–1353
Badawi AF, Eldeen MB, Liu Y et al (2004) Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Res 64:1181–1189
Kubatka P, Ahlers I, Ahlersova E et al (2003) Chemoprevention of mammary carcinogenesis in female rats by rofecoxib. Cancer Lett 202:131–136
Mehta RG (2000) Experimental basis for the prevention of breast cancer. Eur J Cancer 36:1275–1282
Roomi MW, Roomi NW, Ivanov V et al (2005) Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 7:R291–R295
Rivera ES, Andrade N, Martin G et al (1994) Induction of mammary tumors in rat by intraperitoneal injection of NMU: histopathology and estral cycle influence. Cancer Lett 86:223–228
Gullino PM, Pettigrew HM, Grantham FH (1975) N-nitrosomethylurea as mammary gland carcinogen in rats. J Natl Cancer Inst 54:401–414
Loscher W, Mevissen M, Haussler B (1997) Seasonal influence on 7, 12-dimethylbenz[a]anthracene-induced mammary carcinogenesis in Sprague–Dawley rats under controlled laboratory conditions. Pharmacol Toxicol 81:265–270
Sumova A, Bendova Z, Sladek M et al (2004) Seasonal molecular timekeeping within the rat circadian clock. Physiol Res 53 Suppl 1:S167–S176
De Jonage-Canonico MB, Lenoir V, Martin A et al (2003) Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague–Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. Breast Cancer Res Treat 79:365–377
Halberg F (1964) Grundlagenforschung zur Ätiologie des Karzinoms. Ärztl Fortb 2:67–77
Kubatka P, Ahlersova E, Ahlers I et al (2002) Variability of mammary carcinogenesis induction in female Sprague–Dawley and Wistar:Han rats: the effect of season and age. Physiol Res 51:633–640
Lu J, Jiang C, Mitrenga T et al (1998) Pathogenic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat. Carcinogenesis 19:223–227
Reznik G, Ward JM (1981) Morphology of neoplastic lesions in the clitoral and prepucial gland of the F334 rat. J Cancer Res Clin Oncol 101:249–263
Eustis SL, Haseman JK, Mackenzie WF et al (1995) Toxicity and carcinogenicity of 2, 3-dibromo-1-propanol in F344/N rats and B6C3F1 mice. Fundam Appl Toxicol 26:41–50
Ito O, Okamoto T, Fujimoto N et al (1994) Inhibition of mammary tumours by pretreatment with 17 beta-estradiol in F344 rats induced with N-methyl-N-nitrosourea. Jpn J Cancer Res 85:279–283
Workman P, Balmain A, Hickman JA et al (1988) UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim 22:195–201
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perše, M., Cerar, A., Injac, R. et al. N-methylnitrosourea Induced Breast Cancer in Rat, the Histopathology of the Resulting Tumours and its Drawbacks as a Model. Pathol. Oncol. Res. 15, 115–121 (2009). https://doi.org/10.1007/s12253-008-9117-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-008-9117-x